Clovis Oncology, Inc. (CLVS) Stock Soars Amid Continuing Meme Stock Phenomenon
Clovis Oncology, Inc. (CLVS) stock prices were up by 4.77% as of the market closing on June 8th, 2021, bringing the price per share up to USD$5.71 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 18.21% bringing it up to USD$6.75. Get the hottest stocks […]
Annovis Bio, Inc. (ANVS) Stock Skyrockets Following Success of Clinical Trial and Subsequent Public Offering
Annovis Bio, Inc. (ANVS) stock prices skyrocketed by a staggering 127.27% as of the market closing on May 21st, 2021, bringing the price per share up to an even USD$60.00. ANVS401 Study The company announced on May 21st, 2021 the success of its double-blind placebo-controlled study in the treatment of Alzheimer’s Disease. Patients treated with […]
Clovis Oncology, Inc. (CLVS) Stock Trending Up Following Disclosure of Promising Q1 2021 Financial Reports
Clovis Oncology, Inc. (CLVS) stock prices were up a promising 8.89% shortly after the trading day commenced on May 5th, 2021, bringing the price per share up to USD$6.00. Comparative Decrease in Revenue CLVS reported USD$38.1 million in global net product revenues derived from the company’s flagship Rubraca in the first quarter of the fiscal […]